Results 21 to 30 of about 12,970 (163)
Endomyocardial fibrosis and calcification in an elderly patient [PDF]
Tomonobu Yanase +3 more
doaj +2 more sources
Eosinophilia to endomyocardial fibrosis: Documentation of a case
Endomyocardial fibrosis (EMF) is an important cause of restrictive cardiomyopathy in tropical countries. The etiopathogenesis of EMF remains obscure.
Dinkar Bhasin +3 more
doaj +1 more source
Cardiac functions can be altered by changes in the microstructure of the heart, i.e., remodeling of the cardiac tissue, which may activate pathologies such as hypertrophy, dilation, or cardiac fibrosis.
Paola Orozco +2 more
doaj +1 more source
Geographical variation in the clinical presentation of endomyocardial fibrosis in India?
Objectives: To compare the clinical presentation, clinical profile and survival of two groups of endomyocardial fibrosis patients. Methods: The study was a prospective cohort study, or a prospective case series, comparing all consecutive ...
Prabha Nini Gupta +6 more
doaj +1 more source
A endomiocardiofibrose é uma doença comum em países tropicais, particularmente Uganda e Nigéria, e pode acometer tanto o ventrículo esquerdo como direito, gerando uma insuficiência cardíaca restritiva que, além dos sintomas clássicos, manifesta-se por ...
Humberto F.G. de Freitas +3 more
doaj +1 more source
Doughnut appearance of left ventricle in isolated left ventricular endomyocardial fibrosis
A 55-year-old female presented with worsening dyspnea secondary to left ventricular endomyocardial fibrosis (EMF). Obliteration of left ventricular apex and hypertrophied papillary muscle gave the classical appearance of a “doughnut” on left ventricular ...
Mahim Saran +1 more
doaj +1 more source
This is a report of a nine-year-old boy with both mitral stenosis and regurgitation and extensive endomyocardial fibrosis of the left ventricle. Focus is given to the singularity of the fibrotic process, with an emphasis on the etiopathogenic aspects.
Lurildo R. Saraiva +4 more
doaj +1 more source
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu +10 more
wiley +1 more source
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam +3 more
wiley +1 more source
Abstract Background Amyloidosis encompasses a group of diseases characterised by extracellular deposition of misfolded protein fibrils, potentially leading to organ dysfunction. Liver involvement occurs via direct amyloid infiltration, common in immunoglobulin light chain (AL) amyloidosis, or congestive hepatopathy, more typical in transthyretin (ATTR)
M Tang +9 more
wiley +1 more source

